rs724160020
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM1PM2PM5PP3_ModeratePP5_Very_Strong
The ENST00000287295.8(AIFM1):c.1264C>T(p.Arg422Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000182 in 1,098,190 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R422Q) has been classified as Likely pathogenic.
Frequency
Consequence
ENST00000287295.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AIFM1 | NM_004208.4 | c.1264C>T | p.Arg422Trp | missense_variant | 12/16 | ENST00000287295.8 | NP_004199.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AIFM1 | ENST00000287295.8 | c.1264C>T | p.Arg422Trp | missense_variant | 12/16 | 1 | NM_004208.4 | ENSP00000287295 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome AF: 0.00000182 AC: 2AN: 1098190Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 363546
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
Deafness, X-linked 5 Pathogenic:2
Likely pathogenic, no assertion criteria provided | clinical testing | Deafness Gene Diagnosis, Xijing Hospital | - | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Aug 01, 2015 | - - |
not provided Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Sep 01, 2021 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jul 23, 2024 | Published functional studies suggest this variant is associated with impaired dimerization (PMID: 36751702); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 25986071, 28967629, 34416374, 32684920, 38374194, 37405018, 36751702, 31850270) - |
AIFM1-related disorder Pathogenic:1
Likely pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 19, 2024 | The AIFM1 c.1264C>T variant is predicted to result in the amino acid substitution p.Arg422Trp. This variant has been reported in male individuals with X-linked auditory neuropathy spectrum disorder (ANSD) and/or hearing loss (Zong et al. 2015. PubMed ID: 25986071; Bazazzadegan et al. 2019. PubMed ID: 31850270; Wang et al. 2020. PubMed ID: 32684920; Guan et al. 2021. PubMed ID: 34416374). In one of those families, this variant has been observed to segregate with ANSD, with female carriers not reporting any signs of ANSD or peripheral sensory neuropathy (Zong et al. 2015. PubMed ID: 25986071). This variant has not been reported in a large population database, indicating this variant is rare. A different substitution affecting the same amino acid (p.Arg422Gln) has also been documented in association with ANSD (Zong et al. 2015. PubMed ID: 25986071). This variant is interpreted as likely pathogenic. - |
Severe X-linked mitochondrial encephalomyopathy Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Apr 18, 2023 | - - |
Ear malformation Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Kariminejad - Najmabadi Pathology & Genetics Center | Jul 10, 2021 | - - |
Combined oxidative phosphorylation deficiency;CN118851:Charcot-Marie-Tooth Neuropathy X Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 26, 2020 | For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Arg422 amino acid residue in AIFM1. Other variant(s) that disrupt this residue have been observed in individuals with AIFM1-related conditions (PMID: 25986071), which suggests that this may be a clinically significant amino acid residue. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt AIFM1 protein function. This variant has been observed in individual(s) with clinical features of AIFM1-related conditions (PMID: 25986071, 31850270). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 162479). This variant is not present in population databases (ExAC no frequency). This sequence change replaces arginine with tryptophan at codon 422 of the AIFM1 protein (p.Arg422Trp). The arginine residue is highly conserved and there is a moderate physicochemical difference between arginine and tryptophan. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at